NICOLE HAMMOND: Open Payments
NPI 1083256911 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64 in 4 payments from 2 companies in 2025. Trend: 2023 $160 · 2024 $69 · 2025 $64
Food & beverage: $64
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $47 |
| MILLICENT US INC | 1 | $17 |
Products named: Veozah, INTRAROSA.
Industry payments across MD — which companies pay providers there.
